Search

Your search keyword '"Johannes Berkhof"' showing total 336 results

Search Constraints

Start Over You searched for: Author "Johannes Berkhof" Remove constraint Author: "Johannes Berkhof"
336 results on '"Johannes Berkhof"'

Search Results

1. PrimerX: A Bayesian Multistage Cohort Embedded Randomised Trial to Evaluate the Role of Deferred Local Therapy of the Primary Tumour in Combination with Immune Checkpoint Inhibitor–based First-line Therapy in Metastatic Renal Cell Carcinoma Patients

2. Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof‐of‐principle study and call to action

Catalog

Books, media, physical & digital resources

3. Adaptive behavior assessed by Vineland‐3 as comprehensive outcome measure in vanishing white matter

4. Minimally invasive versus open pancreatoduodenectomy for pancreatic and peri-ampullary neoplasm (DIPLOMA-2): study protocol for an international multicenter patient-blinded randomized controlled trial

5. Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates

6. Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.

7. Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands

8. Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India

9. A longitudinal study on quality of life along the spectrum of Alzheimer’s disease

10. Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer’s disease

11. Determinants of informal care time, distress, depression, and quality of life in care partners along the trajectory of Alzheimer's disease

12. A progressive three-state model to estimate time to cancer: a likelihood-based approach

13. Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later

14. Risk of cervical precancer among HPV-negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study.

15. DNA Methylation Analysis to predict Regression of high-grade anal Intraepithelial Neoplasia in HIV+ men (MARINE): a cohort study protocol

16. Biomarker testing in MCI patients—deciding who to test

17. Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study

18. Added value of amyloid PET in individualized risk predictions for MCI patients

19. Personalized risk for clinical progression in cognitively normal subjects—the ABIDE project

20. Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies

21. Optimal treatment of opioid induced constipation in daily clinical practice – an observational study

22. Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer

23. The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment

24. HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control

25. Role of FAM19A4/miR124-2 methylation analysis in predicting regression or non-regression of CIN2/3 lesions: a protocol of an observational longitudinal cohort study

26. Resilience of a FIT screening programme against screening fatigue: a modelling study

27. Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao.

28. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models

29. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.

30. Predictive Value of C-Reactive Protein for Major Complications after Major Abdominal Surgery: A Systematic Review and Pooled-Analysis.

31. Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models.

32. Correlation of minimal residual disease cell frequency with molecular genotype in patients with acute myeloid leukemia

33. Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme

34. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study

35. Clinical validation of methylation biomarkers for optimal detection of high-grade vulvar intraepithelial neoplasia

36. Reply to P. Castle et al

37. Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine

39. Supplementary Figure S1 from Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing

40. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women

42. Supplemental Tables S1-2 from A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma

43. Supplementary Methods from Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples

44. Data from Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA–Positive Women

45. Editorial from Primary hrHPV DNA Testing in Cervical Cancer Screening: How to Manage Screen-Positive Women? A POBASCAM Trial Substudy

46. Data from Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma

47. Supplementary Figures and Tables from Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples

48. Data from A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma

49. Data from Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples